One Stop Solution For In-Depth Market Research Reports


Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Nucleic Acid Amplification Testing (NAAT) Market

[ 英語タイトル ] Nucleic Acid Amplification Testing (NAAT) Market - Growth, Trends, and Forecast (2020 - 2025)

Product Code : MDHC0084134
Survey : Mordor Intelligence
Publish On : November, 2020
Category : Healthcare and Pharmaceuticals
Study Area : Global
Report format : PDF
Sales price option (consumption tax not included)
Single User USD4250 / Question Form
5 User USD4750 / Question Form
Enterprise User USD7500 / Question Form
- Abbott Laboratories
- Becton, Dickinson and Company
- bioMérieux SA
- Bio-Rad Laboratories, Inc.
- Grifols SA
- Hoffmann-La Roche Ltd
- Hologic, Inc.
- Illumina, Inc.

[Report Description]

Market Overview

The major factors for the growth of the nucleic acid amplification testing (NAAT) market include the rising prevalence of infectious diseases, increasing demand for advanced diagnostic measures, and rising investment for the development of new biotechnological diagnostic techniques.
The nucleic acid amplification tests (NAAT) offer sensitive detection, particularly when detecting low-density parasitaemias. The market is expected to witness high growth owing to the rise in preference for NAAT over traditional diagnostic testings. NAAT detects particular nucleic acid, virus, or bacteria which acts as a pathogen in blood, tissue, urine, etc. Furthermore, this technique is also used for screening blood donations to reduce the risk of transfusion-transmitted infections in the recipients. Also, there is a rising prevalence of various infectious diseases which is expected to boost the growth of the market over the forecast period.

Scope of the Report

As per the scope of this report, nucleic acid amplification tests (NAAT) are used to detect a particular nucleic acid, virus, or bacteria which acts as a pathogen in blood, tissue, and urine. The market is segmented by technique, application, and geography.

Key Market Trends

Infectious Disease is the Segment by Application expected to Hold Largest Market Share over the Forecast Period

The major factor driving the growth of the segment is the rising prevalence of various infectious diseases across the globe. For instance, as per the WHO’s 2017 Global Tuberculosis Report, approximately 6.3 million new cases of tuberculosis (TB) were reported in 2016. The report also estimated that the new cases corresponded to 61% of the estimated incidence of 10.4 million TB cases. The NAAT are generally specific and highly sensitive and can be used for all categories of microorganisms. The recent advances have led to the development of multiplex assays. In the multiplex assays, the single nucleic acid-based test can detect and differentiate between more than two causative microorganisms. Thus, owing to the all above-mentioned factors the market is expected to witness high growth over the forecast period.

North America is Expected to Hold Largest Market Share over the Forecast Period

The United States is expected to be the largest nucleic acid amplification testing market owing to the presence of better healthcare infrastructure and the rising prevalence of infectious diseases. In Canada the Canadian Blood Services implemented NAAT and it is providing safer blood supply by detecting low levels of viral genetic material. Furthermore, NAAT is becoming the standard of practice in the blood and plasma industry in the United States and around the world. On the other hand, WHO recommends that the use of NAATs be considered only for research purposes until more evidence is available on the public health impact of detecting and treating low-density infections. Thus, considering all the above-mentioned factors the market is expected to witness high growth.

Competitive Landscape

The market studied is a consolidated market owing to the presence of a few major market players. Some of the market players are Abbott Laboratories, Becton, Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories, Inc., Grifols SA, Hoffmann-La Roche Ltd, Hologic, Inc., and Illumina, Inc.

Reasons to Purchase this report:

- The market estimate (ME) sheet in Excel format
- Report customization as per the client's requirements
- 3 months of analyst support

1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study



4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Prevalence of Infectious Diseases
4.2.2 Increasing Demand for Advanced Diagnostic Measures
4.2.3 Rising Investment for the Development of New Biotechnological Diagnostic Techniques
4.3 Market Restraints
4.3.1 Lack of Skilled Professionals
4.3.2 High Cost
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5.1 By Technique
5.1.1 Target Amplification Systems
5.1.2 Probe Amplification Systems
5.1.3 Signal Amplification Systems
5.2 By Application
5.2.1 Infectious Disease
5.2.2 Cancer
5.2.3 Personalized Medicine
5.2.4 Others
5.3 Geography
5.3.1 North America US Canada Mexico
5.3.2 Europe Germany UK France Italy Spain Rest of Europe
5.3.3 Asia Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.3.4 Middle East and Africa GCC South Africa Rest of Middle East and Africa
5.3.5 South America Brazil Argentina Rest of South America

6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 Becton, Dickinson and Company
6.1.3 bioMérieux SA
6.1.4 Bio-Rad Laboratories, Inc.
6.1.5 Grifols SA
6.1.6 Hoffmann-La Roche Ltd
6.1.7 Hologic, Inc.
6.1.8 Illumina, Inc.




Recommended reports